The table below shows Vir Biotechnology, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$132.39M
-$78.12M
-$109.39M
-$125.78M
$550.09M
-$89.53M
Capital expenditure
$390.00K
$1.63M
$1.87M
$6.87M
$15.84M
$667.00K
Investing cash flow
$11.84M
$126.82M
$28.42M
$98.08M
-$105.39M
$87.53M
Dividends paid
-
-
-
-
VIR operating cash flow (10-K history)
Vir Biotechnology, Inc. reported operating cash flow of -$391.78M for fiscal year 2025. That is up 12.2% from -$446.35M in fiscal 2024. Over the 9 fiscal years shown, operating cash flow declined from -$66.38M (FY 2017) to -$391.78M. Figures come from the company's audited annual reports as filed with the SEC.